Notices of Correction  by unknown
punishing our readers as much as sneaky authors. I think,
however, that the message is clear: We take disclosure of
relationships that might influence article content very
seriously.
As does every student of the issue of COI, I know that
this approach is not enough. What about our reviewers? Are
they in competition with the author of an article they re-
view? Does personal animosity exist? Is there potential gain
to the reviewer by looking favorably on certain work? How
can a pragmatic approach to running the Journal be bal-
anced with these incredibly complex issues?
I have decided to make two important changes in Journal
policy to try to manage these issues. First, we will ask all
reviewers that which we should not ask of them: “Does this
article in any way raise the potential of a conflict of interest?”
We are also going to incorrectly allow the reviewer to manage
that potential conflict by stating that he or she does not believe
any potential conflict prohibits him or her from providing a
good, scientifically valid review. Ultimately, all reviews are
judged by me and my associate editors in the context of other
reviews and of our own impressions of the submitted work.
Second, and more important, we have established a for-
mal system for managing disclosures. Led by our ethics
editor, Dr Martin McKneally, we are convening a panel
whose members will review the disclosures of all authors as
they relate to any article accepted for publication. When the
ethics panel believes a conflict exists, we will publish the
disclosures of the authors.
Finally, we must acknowledge that every system remains
at the mercy of our authors and of our belief in the inherent
honesty and desire to “do the right thing” that has been a
hallmark of our profession and specialty over the years. We
assert the belief that our authors are persons of character and
accept the notion that character is doing the right thing when
no one is looking. If an author offends us by displaying a
lack of character, we believe our disciplinary action is
appropriate.
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Notices of Correction
In the June 2005 issue of the Journal, the article by Dr. Gillinov and associates titled “Surgical
ablation of atrial fibrillation with bipolar radiofrequency as the primary modality” (2005;129:1322-9)
contained incomplete disclosure statements. Dr. Gillinov provided the following additional informa-
tion: Drs. McCarthy and Gillinov were consultants to Atricure, Inc when the manuscript was written.
Dr. Gillinov has no equity interest in Atricure, Inc. At the time of manuscript submission, Dr.
McCarthy did not have an equity interest in Atricure, Inc. Dr. Cosgrove previously served on the
Board of Directors of Atricure, Inc. The Cleveland Clinic has an interest in a venture capital fund
which has an investment in Atricure, Inc.
In the October 2004 issue of the Journal, pursuant to the article by Dr. Gaynor and associates titled
“A prospective, single-center clinical trial of a modified Cox maze procedure with bipolar radiofre-
quency ablation” (2004;128:535-42), the authors disclosed to the Journal that Dr. Schuessler and Dr.
Damiano were consultants to Atricure, Inc. The Journal did not include this information with the
article. In a follow-up inquiry, Dr. Damiano indicated that his disclosure and that of Dr. Schuessler
were complete and that neither had stock ownership, equity interest, or patient license arrangements
with Atricure.
In the September 2005 issue of the Journal, pursuant to the article by Dr. Wolf and associates titled
“Video-assisted bilateral pulmonary vein isolation and left atrial appendage exclusion for atrial
fibrillation” (2005;130:797-802), the authors disclosed in their initial cover letter to the Journal only
that Drs. Schneeberger, Gillinov and Wolf received educational grants from Atricure that were not
used to fund this research. In a follow-up response to further inquiry, Dr. Wolf disclosed the following
information: He was, at the time of manuscript submission, a consultant to Atricure and had equity
interests in the form of option shares and warrants that were less than 0.5% ownership of the company.
Dr. Gillinov was a consultant to Atricure in November of 2004. Dr. Schneeberger was a consultant in
November of 2004 and had equity interests consisting of option shares in the company that were less
than 0.5% ownership of the company. Dr. Flege is a member of the Event Adjudication Committee
of Atricure, is paid by the hour and worked a total of one hour during the last 2 years.
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